Compare LEXX & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LEXX | BYFC |
|---|---|---|
| Founded | 2004 | 1946 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5M | 57.1M |
| IPO Year | N/A | 1996 |
| Metric | LEXX | BYFC |
|---|---|---|
| Price | $0.57 | $5.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 6.2K |
| Earning Date | 01-09-2026 | 01-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $705,923.00 | ★ $33,412,000.00 |
| Revenue This Year | $13.35 | N/A |
| Revenue Next Year | $78.83 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 52.05 | N/A |
| 52 Week Low | $0.48 | $5.51 |
| 52 Week High | $2.43 | $9.46 |
| Indicator | LEXX | BYFC |
|---|---|---|
| Relative Strength Index (RSI) | 31.42 | 47.08 |
| Support Level | $0.48 | $5.65 |
| Resistance Level | $0.70 | $6.08 |
| Average True Range (ATR) | 0.12 | 0.28 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 9.27 | 45.80 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.